WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (93)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, H.-M.
Right arrow Articles by Liu, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, H.-M.
Right arrow Articles by Liu, B.

 Previous Article  |  Next Article 

The Journal of Neuroscience, February 15, 2003, 23(4):1228

Synergistic Dopaminergic Neurotoxicity of the Pesticide Rotenone and Inflammogen Lipopolysaccharide: Relevance to the Etiology of Parkinson's Disease

Hui-Ming Gao1, 2, Jau-Shyong Hong1, Wanqin Zhang2, and Bin Liu1

1 Neuropharmacology Section, Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences/National Institutes of Health, Research Triangle Park, North Carolina 27709, and 2 Department of Physiology, Dalian Medical University, Dalian, 116027, China

Parkinson's disease (PD) is characterized by a progressive degeneration of the nigrostriatal dopaminergic pathway resulting in movement disorders. Although its etiology remains unknown, PD may be the final outcome of interactions among multiple factors, including exposure to environmental toxins and the occurrence of inflammation in the brain. In this study, using primary mesencephalic cultures, we observed that nontoxic or minimally toxic concentrations of the pesticide rotenone (0.5 nM) and the inflammogen lipopolysaccharide (LPS) (0.5 ng/ml) synergistically induced dopaminergic neurodegeneration. The synergistic neurotoxicity of rotenone and LPS was observed when the two agents were applied either simultaneously or in tandem. Mechanistically, microglial NADPH oxidase-mediated generation of reactive oxygen species appeared to be a key contributor to the synergistic dopaminergic neurotoxicity. This conclusion was based on the following observations. First, inhibition of NADPH oxidase or scavenging of free radicals afforded significant neuroprotection. Second, rotenone and LPS synergistically stimulated the NADPH oxidase-mediated release of the superoxide free radical. Third and most importantly, rotenone and LPS failed to induce the synergistic neurotoxicity as well as the production of superoxide in cultures from NADPH oxidase-deficient animals. This is the first demonstration that low concentrations of a pesticide and an inflammogen work in synergy to induce a selective degeneration of dopaminergic neurons. Findings from this study may be highly relevant to the elucidation of the multifactorial etiology of PD and the discovery of effective therapeutic agents for the treatment of the disease.

Key words: pesticide; inflammation; microglia; NADPH oxidase; Parkinson's disease; synergistic neurotoxicity

Copyright © 2003 Society for Neuroscience  0270-6474/03/2341228-09$05.00/0


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
Y.-T. Shih, I.-J. Chen, Y.-C. Wu, and Y.-C. Lo
San-Huang-Xie-Xin-Tang Protects Against Activated Microglia- and 6-OHDA-induced Toxicity in Neuronal SH-SY5Y Cells
Evid. Based Complement. Altern. Med., April 1, 2009; (2009) nep025v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. C. Frank-Cannon, T. Tran, K. A. Ruhn, T. N. Martinez, J. Hong, M. Marvin, M. Hartley, I. Trevino, D. E. O'Brien, B. Casey, et al.
Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
J. Neurosci., October 22, 2008; 28(43): 10825 - 10834.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H.-M. Gao, P. T. Kotzbauer, K. Uryu, S. Leight, J. Q. Trojanowski, and V. M.-Y. Lee
Neuroinflammation and Oxidation/Nitration of {alpha}-Synuclein Linked to Dopaminergic Neurodegeneration
J. Neurosci., July 23, 2008; 28(30): 7687 - 7698.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J. Wang and S. Dore
Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage
Brain, June 1, 2007; 130(6): 1643 - 1652.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L.-P. Liang, J. Huang, R. Fulton, B. J. Day, and M. Patel
An Orally Active Catalytic Metalloporphyrin Protects against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity In Vivo
J. Neurosci., April 18, 2007; 27(16): 4326 - 4333.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. P. Mount, A. Lira, D. Grimes, P. D. Smith, S. Faucher, R. Slack, H. Anisman, S. Hayley, and D. S. Park
Involvement of Interferon-{gamma} in Microglial-Mediated Loss of Dopaminergic Neurons
J. Neurosci., March 21, 2007; 27(12): 3328 - 3337.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Yang, J. Yang, Z. Yang, P. Chen, A. Fraser, W. Zhang, H. Pang, X. Gao, B. Wilson, J.-S. Hong, et al.
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) 38 and PACAP4-6 Are Neuroprotective through Inhibition of NADPH Oxidase: Potent Regulators of Microglia-Mediated Oxidative Stress
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 595 - 603.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
Y. Zhou, Y. Wang, M. Kovacs, J. Jin, and J. Zhang
Microglial Activation Induced by Neurodegeneration: A Proteomic Analysis
Mol. Cell. Proteomics, October 1, 2005; 4(10): 1471 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S M Hague, S Klaffke, and O Bandmann
Neurodegenerative disorders: Parkinson's disease and Huntington's disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1058 - 1063.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
W. Zhang, T. Wang, Z. Pei, D. S. Miller, X. Wu, M. L. Block, B. Wilson, W. Zhang, Y. Zhou, J.-S. Hong, et al.
Aggregated {alpha}-synuclein activates microglia: a process leading to disease progression in Parkinson's disease
FASEB J, April 1, 2005; 19(6): 533 - 542.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
L. Qin, M. L. Block, Y. Liu, R. J. Bienstock, Z. Pei, W. Zhang, X. Wu, B. Wilson, T. Burka, and J.-S. Hong
Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress
FASEB J, April 1, 2005; 19(6): 550 - 557.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Cho, E.-M. Park, M. Febbraio, J. Anrather, L. Park, G. Racchumi, R. L. Silverstein, and C. Iadecola
The Class B Scavenger Receptor CD36 Mediates Free Radical Production and Tissue Injury in Cerebral Ischemia
J. Neurosci., March 9, 2005; 25(10): 2504 - 2512.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Qin, Y. Liu, T. Wang, S.-J. Wei, M. L. Block, B. Wilson, B. Liu, and J.-S. Hong
NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia
J. Biol. Chem., January 9, 2004; 279(2): 1415 - 1421.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H.-M. Gao, B. Liu, and J.-S. Hong
Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons
J. Neurosci., July 16, 2003; 23(15): 6181 - 6187.
[Abstract] [Full Text] [PDF]


-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-